Melinta Therapeutics to Participate in Two Upcoming Investor Conferences

Melinta Therapeutics, a privately held commercial-stage company developing novel antibiotics to treat serious bacterial infections, announced that it will be presenting at the following upcoming investor conferences:

  • Ladenburg Thalmann 2017 Healthcare Conference at 10:00 a.m. on September 26, 2017.
  • Cantor Fitzgerald Global Healthcare Conference at 8:00 a.m. on September 27, 2017.